blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1853591

EP1853591 - METHOD FOR OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND (IRBESARTAN) AND ITS SYNTHESIS INTERMEDIATE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.10.2010
Database last updated on 02.07.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
INKE, S.A.
Pol. Ind. Can Pelegri- C. Argent, 1
08755 Castellbisbal / ES
[2007/46]
Inventor(s)01 / HUGUET CLOTET, Joan
Riera D'en Nofre 11 6A
08970 Sant Joan Despi / ES
02 / DALMASES BARJOAN, Pere
Pi I Maragall 7
E-08980 Sant Feliu De Llobregat / ES
 [2008/02]
Former [2007/46]01 / HUGUET CLOTET, Joan
Riera D'en Nofre, 11-13
E-08970 Sant Joan Despi / ES
02 / DALMASES BARJOAN, Pere
Pi I Maragall 7
E-08980 Sant Feliu De Llobregat / ES
Representative(s)Ponti Sales, Adelaida
Oficina Ponti
C. Consell de Cent, 322
08007 Barcelona / ES
[N/P]
Former [2009/29]Ponti Sales, Adelaida
Oficina Ponti C. Consell de Cent 322
08007 Barcelona / ES
Former [2007/46]Ponti Sales, Adelaida
C. de Consell de Cent 322
08007 Barcelona / ES
Application number, filing date06708469.923.02.2006
[2007/46]
WO2006EP60208
Priority number, dateES2005000048528.02.2005         Original published format: ES 200500485
US20050685912P31.05.2005         Original published format: US 685912 P
ES2005000316623.12.2005         Original published format: ES 200503166
[2007/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006089927
Date:31.08.2006
Language:EN
[2006/35]
Type: A1 Application with search report 
No.:EP1853591
Date:14.11.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 31.08.2006 takes the place of the publication of the European patent application.
[2007/46]
Type: B1 Patent specification 
No.:EP1853591
Date:25.11.2009
Language:EN
[2009/48]
Search report(s)International search report - published on:EP31.08.2006
ClassificationIPC:C07D403/10, C07F5/02, C07D235/02
[2007/46]
CPC:
C07D235/02 (EP,ES,US); C07D403/10 (EP,ES,KR,US); C07F5/02 (ES)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/46]
Extension statesAL12.09.2007
BA12.09.2007
HR12.09.2007
MK12.09.2007
YU12.09.2007
TitleGerman:VERFAHREN ZUR GEWINNUNG EINER PHARMAZEUTISCH WIRKSAMEN VERBINDUNG (IRBESATAN) UND ZWISCHENPRODUKT FÜR IHRE SYNTHESE[2007/46]
English:METHOD FOR OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND (IRBESARTAN) AND ITS SYNTHESIS INTERMEDIATE[2007/46]
French:PROCEDE POUR L'OBTENTION D'UN COMPOSE PHARMACEUTIQUEMENT ACTIF (IRBESARTAN) ET SON INTERMEDIAIRE DE SYNTHESE[2007/46]
Entry into regional phase21.08.2007National basic fee paid 
21.08.2007Designation fee(s) paid 
21.08.2007Examination fee paid 
Examination procedure21.08.2007Amendment by applicant (claims and/or description)
21.08.2007Examination requested  [2007/46]
17.04.2008Despatch of a communication from the examining division (Time limit: M06)
26.09.2008Reply to a communication from the examining division
12.06.2009Communication of intention to grant the patent
30.09.2009Fee for grant paid
30.09.2009Fee for publishing/printing paid
Opposition(s)26.08.2010No opposition filed within time limit [2010/44]
Fees paidRenewal fee
21.08.2007Renewal fee patent year 03
17.12.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.11.2009
BE25.11.2009
CY25.11.2009
CZ25.11.2009
DK25.11.2009
EE25.11.2009
FI25.11.2009
IT25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
RO25.11.2009
SE25.11.2009
SI25.11.2009
SK25.11.2009
TR25.11.2009
IE23.02.2010
LU23.02.2010
BG25.02.2010
GB25.02.2010
GR26.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
ES08.03.2010
IS25.03.2010
PT25.03.2010
HU26.05.2010
[2012/47]
Former [2012/43]AT25.11.2009
BE25.11.2009
CY25.11.2009
CZ25.11.2009
DK25.11.2009
EE25.11.2009
FI25.11.2009
IT25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
RO25.11.2009
SE25.11.2009
SI25.11.2009
SK25.11.2009
IE23.02.2010
LU23.02.2010
BG25.02.2010
GB25.02.2010
GR26.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
ES08.03.2010
IS25.03.2010
PT25.03.2010
HU26.05.2010
Former [2012/42]AT25.11.2009
BE25.11.2009
CY25.11.2009
CZ25.11.2009
DK25.11.2009
EE25.11.2009
FI25.11.2009
IT25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
RO25.11.2009
SE25.11.2009
SI25.11.2009
SK25.11.2009
IE23.02.2010
BG25.02.2010
GB25.02.2010
GR26.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
ES08.03.2010
IS25.03.2010
PT25.03.2010
HU26.05.2010
Former [2011/17]AT25.11.2009
BE25.11.2009
CY25.11.2009
CZ25.11.2009
DK25.11.2009
EE25.11.2009
FI25.11.2009
IT25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
RO25.11.2009
SE25.11.2009
SI25.11.2009
SK25.11.2009
IE23.02.2010
BG25.02.2010
GB25.02.2010
GR26.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
ES08.03.2010
IS25.03.2010
PT25.03.2010
Former [2011/09]AT25.11.2009
BE25.11.2009
CY25.11.2009
CZ25.11.2009
DK25.11.2009
EE25.11.2009
FI25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
RO25.11.2009
SE25.11.2009
SI25.11.2009
SK25.11.2009
IE23.02.2010
BG25.02.2010
GR26.02.2010
CH28.02.2010
LI28.02.2010
FR01.03.2010
MC01.03.2010
ES08.03.2010
IS25.03.2010
PT25.03.2010
Former [2011/04]AT25.11.2009
BE25.11.2009
CY25.11.2009
CZ25.11.2009
DK25.11.2009
EE25.11.2009
FI25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
RO25.11.2009
SE25.11.2009
SI25.11.2009
SK25.11.2009
BG25.02.2010
GR26.02.2010
CH28.02.2010
LI28.02.2010
MC01.03.2010
ES08.03.2010
IS25.03.2010
PT25.03.2010
Former [2010/41]AT25.11.2009
BE25.11.2009
CY25.11.2009
CZ25.11.2009
DK25.11.2009
EE25.11.2009
FI25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
RO25.11.2009
SE25.11.2009
SI25.11.2009
SK25.11.2009
BG25.02.2010
ES08.03.2010
IS25.03.2010
PT25.03.2010
Former [2010/33]AT25.11.2009
BE25.11.2009
CY25.11.2009
FI25.11.2009
LT25.11.2009
LV25.11.2009
NL25.11.2009
PL25.11.2009
SE25.11.2009
SI25.11.2009
ES08.03.2010
IS25.03.2010
PT25.03.2010
Former [2010/31]AT25.11.2009
BE25.11.2009
CY25.11.2009
FI25.11.2009
LT25.11.2009
LV25.11.2009
PL25.11.2009
SE25.11.2009
SI25.11.2009
IS25.03.2010
PT25.03.2010
Former [2010/30]AT25.11.2009
CY25.11.2009
FI25.11.2009
LT25.11.2009
LV25.11.2009
PL25.11.2009
SE25.11.2009
SI25.11.2009
IS25.03.2010
PT25.03.2010
Former [2010/26]CY25.11.2009
FI25.11.2009
LT25.11.2009
LV25.11.2009
PL25.11.2009
SE25.11.2009
SI25.11.2009
IS25.03.2010
PT25.03.2010
Cited inInternational search[Y]US5629331  (CARON ANTOINE [FR], et al);
 [Y]US2002045650  (MACKMAN RICHARD LAURENCE [US]);
 [Y]WO2004039753  (GLAXO GROUP LTD [GB], et al);
 [YDX]WO2004065383  (TEVA PHARMA [IL], et al);
 [X]WO2004072064  (TEVA PHARMA [IL], et al);
 [PX]WO2005102987  (VITA CIENTIFICA S L [ES], et al);
ExaminationDE4313747
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.